# CABAZITAXEL
> **NDA207970** · New Drug Application · Sponsor: ACTAVIS · Approved 2024-03-14
## Drug
- **FDA Application Number:** NDA207970
- **Application type:** New Drug Application
- **Brand name:** CABAZITAXEL
- **Generic name:** Cabazitaxel
- **Active ingredients:** CABAZITAXEL
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** ACTAVIS
- **First approval:** 2024-03-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207970)
---
*MORVS · CC0 1.0*